Daily News Podcast

A hidden bonus for rivaroxaban?

Publish date: September 24, 2018

 

Bleeding from rivaroxaban may help diagnose some GI and GU cancers. Also today, a review by the FDA supports the safety of nuplazid, arthritis is prevalent in older adults with any degree of depression, and growth in overdose deaths is exponential.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Baloxavir, oseltamivir similar for influenza
MDedge Infectious Disease
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Infectious Disease
Danish endocarditis strategy halved hospital days
MDedge Infectious Disease
Review protocols, follow reprocessing guidelines to cut device-related HAIs
MDedge Infectious Disease
CDC opens Emergency Operations Center in advance of Hurricane Florence
MDedge Infectious Disease
Urine drug screens show improper medication use
MDedge Infectious Disease
Alarming rate of diabetes medication discontinuations
MDedge Infectious Disease
Troubling MRI changes and pediatric hypertension
MDedge Infectious Disease
Behavioral intervention in obese adults
MDedge Infectious Disease
What you should know about celiac disease
MDedge Infectious Disease